International Reference Pricing Across Medicare and Medicaid
JAMA · 12.05.2026 · 335 (18) · 1571
DOI: 10.1001/jama.2026.3536 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 12.05.2026. Verfasst von So-Yeon Kang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Management and Policy, Georgetown University School of Health, Washington, DC. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
This Viewpoint discusses 3 US Centers for Medicare & Medicaid Services (CMS) drug pricing models and how a pivot toward international reference pricing could affect consumers, manufacturers, and drug pricing policy.
Autor:innen und Institutionen
- Department of Health Management and Policy, Georgetown University School of Health, Washington, DC.
- Cancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC.
- Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora.
Zitieren
APA
Kang, S. Y., & DiStefano, M. J. (2026). International Reference Pricing Across Medicare and Medicaid. JAMA, 335(18), 1571. https://doi.org/10.1001/jama.2026.3536
Vancouver
Kang SY, DiStefano MJ. International Reference Pricing Across Medicare and Medicaid. JAMA. 2026;335(18):1571. doi:10.1001/jama.2026.3536
BibTeX
@article{Kang2026,
author = {Kang, So-Yeon and DiStefano, Michael J},
title = {International Reference Pricing Across Medicare and Medicaid},
journal = {JAMA},
year = {2026},
volume = {335},
number = {18},
pages = {1571},
doi = {10.1001/jama.2026.3536}
}
EUVIMED